Literature DB >> 9122234

Obesity increases sensitivity to endotoxin liver injury: implications for the pathogenesis of steatohepatitis.

S Q Yang1, H Z Lin, M D Lane, M Clemens, A M Diehl.   

Abstract

Genetically obese fatty/fatty rats and obese/obese mice exhibit increased sensitivity to endotoxin hepatotoxicity, quickly developing steatohepatitis after exposure to low doses of lipopolysaccharide (LPS). Among obese animals, females are more sensitive to endotoxin liver injury than males. LPS induction of tumor necrosis factor alpha (TNF alpha), the proven affecter of endotoxin liver injury, is no greater in the livers, white adipose tissues, or sera of obese animals than in those of lean controls. Indeed, the lowest serum concentrations of TNF occur in female obese rodents, which exhibit the most endotoxin-induced liver injury. Several cytokines that modulate the biological activity of TNF are regulated abnormally in the livers of obese animals. After exposure to LPS, mRNA of interferon gamma, which sensitizes hepatocytes to TNF toxicity, is overexpressed, and mRNA levels of interleukin 10, a TNF inhibitor, are decreased. The phagocytic activity of liver macrophages and the hepatic expression of a gene encoding a macrophage-specific receptor are also decreased in obesity. This new animal model of obesity-associated liver disease demonstrates that hepatic macrophage dysfunction occurs in obesity and suggests that this might promote steatohepatitis by sensitizing hepatocytes to endotoxin.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9122234      PMCID: PMC20127          DOI: 10.1073/pnas.94.6.2557

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  48 in total

Review 1.  Immunotoxicology of host-response-mediated experimental liver injury.

Authors:  G Tiegs
Journal:  J Hepatol       Date:  1994-11       Impact factor: 25.083

2.  Role of proinflammatory cytokines in acetaminophen hepatotoxicity.

Authors:  M E Blazka; J L Wilmer; S D Holladay; R E Wilson; M I Luster
Journal:  Toxicol Appl Pharmacol       Date:  1995-07       Impact factor: 4.219

3.  The role of tumor necrosis factor-alpha in acute endotoxin-induced hepatotoxicity in ethanol-fed rats.

Authors:  J Hansen; D L Cherwitz; J I Allen
Journal:  Hepatology       Date:  1994-08       Impact factor: 17.425

4.  Regulation of the mRNA expression for tumor necrosis factor-alpha in rat liver macrophages.

Authors:  M Grewe; R Gausling; K Gyufko; R Hoffmann; K Decker
Journal:  J Hepatol       Date:  1994-06       Impact factor: 25.083

5.  Prevention of carbon tetrachloride-induced rat liver injury by soluble tumor necrosis factor receptor.

Authors:  M J Czaja; J Xu; E Alt
Journal:  Gastroenterology       Date:  1995-06       Impact factor: 22.682

6.  The expression of tumor necrosis factor in human adipose tissue. Regulation by obesity, weight loss, and relationship to lipoprotein lipase.

Authors:  P A Kern; M Saghizadeh; J M Ong; R J Bosch; R Deem; R B Simsolo
Journal:  J Clin Invest       Date:  1995-05       Impact factor: 14.808

7.  Augmented production of tumor necrosis factor-alpha in obese mice.

Authors:  T Yamakawa; S Tanaka; Y Yamakawa; Y Kiuchi; F Isoda; S Kawamoto; K Okuda; H Sekihara
Journal:  Clin Immunol Immunopathol       Date:  1995-04

Review 8.  Control of tumor necrosis factor gene expression.

Authors:  U Pauli
Journal:  Crit Rev Eukaryot Gene Expr       Date:  1994       Impact factor: 1.807

Review 9.  Nonalcoholic steatohepatitis: a study of 49 patients.

Authors:  R G Lee
Journal:  Hum Pathol       Date:  1989-06       Impact factor: 3.466

10.  Nonalcoholic steatohepatitis: an expanded clinical entity.

Authors:  B R Bacon; M J Farahvash; C G Janney; B A Neuschwander-Tetri
Journal:  Gastroenterology       Date:  1994-10       Impact factor: 22.682

View more
  224 in total

Review 1.  New insights into the biology of the acute phase response.

Authors:  A F Suffredini; G Fantuzzi; R Badolato; J J Oppenheim; N P O'Grady
Journal:  J Clin Immunol       Date:  1999-07       Impact factor: 8.317

2.  Lipopolysaccharide induces and activates the Nalp3 inflammasome in the liver.

Authors:  Michal Ganz; Timea Csak; Bharath Nath; Gyongyi Szabo
Journal:  World J Gastroenterol       Date:  2011-11-21       Impact factor: 5.742

3.  Plasma levels of interleukin-18 and interleukin-18 binding protein are elevated in patients with chronic liver disease.

Authors:  Othmar Ludwiczek; Arthur Kaser; Daniela Novick; Charles A Dinarello; Menachem Rubinstein; Wolfgang Vogel; Herbert Tilg
Journal:  J Clin Immunol       Date:  2002-11       Impact factor: 8.317

4.  TIMP-1 deficiency leads to lethal partial hepatic ischemia and reperfusion injury.

Authors:  Sergio Duarte; Takashi Hamada; Naohisa Kuriyama; Ronald W Busuttil; Ana J Coito
Journal:  Hepatology       Date:  2012-07-11       Impact factor: 17.425

5.  Liver regeneration is not altered in patients with nonalcoholic steatohepatitis (NASH) when compared to chronic hepatitis C infection with similar grade of inflammation.

Authors:  Osamah Hussein; Sergio Szvalb; L M Van den Akker-Berman; Nimer Assy
Journal:  Dig Dis Sci       Date:  2002-09       Impact factor: 3.199

Review 6.  Impact of liver diseases on the development of type 2 diabetes mellitus.

Authors:  Po-Shiuan Hsieh; Yen-Ju Hsieh
Journal:  World J Gastroenterol       Date:  2011-12-28       Impact factor: 5.742

7.  Precision-cut liver slices from diet-induced obese rats exposed to ethanol are susceptible to oxidative stress and increased fatty acid synthesis.

Authors:  Michael J Duryee; Monte S Willis; Courtney S Schaffert; Roger D Reidelberger; Anand Dusad; Daniel R Anderson; Lynell W Klassen; Geoffrey M Thiele
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2013-11-27       Impact factor: 4.052

Review 8.  Hepatic steatosis and type 2 diabetes mellitus.

Authors:  Jeanne M Clark; Anna Mae Diehl
Journal:  Curr Diab Rep       Date:  2002-06       Impact factor: 4.810

9.  Effects of low-calorie diet on steatohepatitis in rats with obesity and hyperlipidemia.

Authors:  Jian-Gao Fan; Lan Zhong; Zheng-Jie Xu; Li-Yan Tia; Xiao-Dong Ding; Min-Sheng Li; Guo-Liang Wang
Journal:  World J Gastroenterol       Date:  2003-09       Impact factor: 5.742

10.  Sepsis-induced inflammation is exacerbated in an animal model of type 2 diabetes.

Authors:  Asha Jacob; Marissa L Steinberg; Juntao Yang; Weifeng Dong; Youxin Ji; Ping Wang
Journal:  Int J Clin Exp Med       Date:  2008-01-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.